Published • loading... • Updated
Pfizer and Gilead Sciences vs. Evotec and GlaxoSmithKline – Commented KW 29 Peer Group Watch Pharma, Chemistry, Biotech, Medicine & Health
Summary by Boerse-social.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
In the week view is ahead: Pfizer 3.64% ahead of Biogen Idec 3.43%, Gilead Sciences 3.43%, Merck Co. 3.21%, Stratec Biomedical 2.84%, BASF 2.09%, Lanxess 2.07%, Sanofi 1.46%, Amgen 0.8%, Sartorius 0.58%, Novartis 0.58%, Linde 0.05%, MorphoSys 0%, Baxter International -0.04%, Ibu-Tec -1.01%, Valneva -1.06%, Fresenius -1.97%, BB Biotech -2.08%, Merck KGaA -2.43%, Bayer -3.31%, Roche GS -3.85%, Epigenomics -6.99%, Paion -11.35%, Medigene -12.5%, Gl…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
